Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations
- 1 February 1998
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (2) , 318-321
- https://doi.org/10.1016/s0190-9622(98)70573-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Adrenal function following topical steroid treatment in children with atopic dermatitisBritish Journal of Dermatology, 1995
- Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroidsJournal of the American Academy of Dermatology, 1993
- Contact allergy to corticosteroidsJournal of the American Academy of Dermatology, 1993
- Side Effects of Topical Corticosteroids and their PreventionDrugs, 1988
- Current Treatment Guidelines for Topical CorticosteroidsDrugs, 1988
- Superpotent topical steroid treatment of psoriasis vulgaris—clinical efficacy and adrenal functionJournal of the American Academy of Dermatology, 1987
- Topical clobetasol-17-propionate: Review of its clinical efficacy and safetyJournal of the American Academy of Dermatology, 1986
- Use of glucocorticosteroids in psoriasisPharmacology & Therapeutics, 1980
- FATAL IATROGENIC CUSHING'S SYNDROMEThe Lancet, 1979
- Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.BMJ, 1975